Anavex Names Kellmeyer CEO After Three Resignations, Plans Independent Director Search
Photo: TokenPost
Anavex Life Sciences named interim chief executive Terrie Kellmeyer, Ph.D., president and CEO effective Nov. 1, formalizing its leadership change after three directors resigned over strategic misalignment. Anavex announced the appointment Nov. 3. Jiong Ma, then the board chair, Gautam Patel and Adrian Senderowicz resigned from the board effective Oct. 28. In their resignation letters, the three cited strategic misalignment with the board and management over the company’s direction and business plan. Kellmeyer also joined the board. Anavex reduced the board’s size from six seats to five and plans to seek an independent director for the open seat.
Source: TokenPost
